Skip to main content
Livermore
Livermore
ZHEN

Wealth Architects, LLC

SEC CIK
0001611518
Latest filing
Jul 23, 2026

ARWR holding history

Arrowhead Pharmaceuticals, Inc. in every 13F filed by Wealth Architects, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARWR overviewAll 13F holders of ARWRFull Q2 2026 holdings

Shares (Q2 2026)
12,249
Value
$998.4K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ARWR by Wealth Architects, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,249$998.4K0.1%+20.0%AddedHolders
Q1 202612,247$767.9K0.1%−21−0.2%ReducedHolders
Q4 202512,268$814.5K0.1%+119+1.0%AddedHolders
Q3 202512,149$419.0K<0.1%−112−0.9%ReducedHolders
Q2 202512,261$193.7K<0.1%−180−1.4%ReducedHolders
Q1 202512,441$158.5K<0.1%+331+2.7%AddedHolders
Q4 202412,110$227.7K<0.1%00.0%UnchangedHolders
Q3 202412,110$234.6K<0.1%00.0%UnchangedHolders
Q2 202412,110$314.7K<0.1%00.0%UnchangedHolders
Q1 202412,110$346.3K<0.1%00.0%UnchangedHolders
Q4 202312,110$370.6K0.1%−89−0.7%ReducedHolders
Q3 202312,199$327.8K0.1%00.0%UnchangedHolders
Q2 202312,199$435.0K0.1%−3,000−19.7%ReducedHolders
Q1 202315,199$386.1K0.1%00.0%UnchangedHolders
Q4 202215,199$616.5K0.1%−249−1.6%ReducedHolders
Q3 202215,448$511.0K0.1%00.0%UnchangedHolders
Q2 202215,448$544.0K0.1%−50.0%ReducedHolders
Q1 202215,453$711.0K0.1%00.0%UnchangedHolders
Q4 202115,453$1.02M0.2%00.0%UnchangedHolders
Q3 202115,453$965.0K0.2%00.0%UnchangedHolders
Q2 202115,453$1.28M0.3%+364+2.4%AddedHolders
Q1 202115,089$1.00M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.